Zhe Zhang
Professor Supervisor of Doctorate Candidates Supervisor of Master's Candidates
Name (Simplified Chinese):张哲
Name (English):Zhe Zhang
Date of Employment:2021-01
School/Department:School of Basic Medical Sciences
Administrative Position:Professor
Education Level:Postgraduate (Doctoral)
Business Address:Room 209, Electron Microscopy Building, No.44 Wenhua Xi Road,
Shandong University School of Basic Medical Sciences, Ji'nan, Shandong
250012, P.R.China
Gender:Male
Contact Information:
Degree:Doctor
Other Post:Aging,Cancer,Cancer Genetics,Oncology Letters,General Physiology and Biophysics ,Experimental and Therapeutic Medicine,Food & Function, Psychosomatic Medicine Research(Section Editor), Current Pharmaceutical Biotechnology, 中国生物工程杂志,解剖科学进展
Alma Mater:Tsinghua University
College:School of Basic Medical Sciences
Discipline:Genetics
Developmental Biology
Biochemistry and Molecular Biology
Hits:
Title of Paper:FLVCR2: structure, substrate transport, and emerging roles in human disease
Journal:Life Sciences
Key Words:FLVCR2; Solute carrier; Choline transport; Blood-brain barrier; Fowler syndrome; Ferroptosis
Summary:The feline leukemia virus subgroup C receptor 2 (FLVCR2), a key member of the solute carrier (SLC) major facilitator superfamily (MFS), is a highly conserved transmembrane protein with diverse and critical functions in mammalian biology. Although once proposed as an extracellular heme importer, recent functional and structural studies strongly support FLVCR2 as a primary choline transporter, notably at the blood-brain barrier (BBB). Cryo-electron microscopy (cryo-EM) has resolved the outward-facing (OFS) and inward-facing (IFS) conformations, providing a molecular understanding of its classic MFS fold and the proposed proton-dependent rocker-switch mechanism for choline transport. This structural clarity definitively resolves the primary substrate debate. Mutations in FLVCR2 are the cause of Fowler syndrome (PVHH), resulting from severely impaired central nervous system (CNS) vascular development. Beyond this, FLVCR2 maintains systemic heme homeostasis, with its deficiency linked to exacerbation of hemolytic-induced lung injury via ferroptosis. Finally, its role in choline transport makes its upregulation in malignancies, such as acute myeloid leukemia (AML), significant, positioning FLVCR2 as a potential prognostic tumor biomarker and therapeutic target. Further research is necessary to fully exploit its clinical potential.
First Author:Liyuan Huang,Mengxiao Wu,Meixi Gong
Correspondence Author:Zhe Zhang
All the Authors:Lingfan Zhu,Chen Zhang,Yujie Ding
Volume:390
DOI Number:10.1016/j.lfs.2026.124269
Translation or Not:No
Date of Publication:2026-04
Included Journals:SCI
Links to Published Journals:https://www.sciencedirect.com/science/article/pii/S0024320526000779?dgcid=author
Release Time:2026-06-12